FGF23 and chronic kidney disease: Furthermore, we found that the CKD-driven increase in osteoblastic and osteocytic Fgf23 secretion contributes to the mineralization defect in murine CKD-MDB by auto-/paracrine suppression of TNAP and subsequent accumulation of pyrophosphate in bone.